Pictet Asset Management’s ADMA Biologics ADMA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.09M | Buy |
169,862
+133,950
| +373% | +$2.43M | ﹤0.01% | 832 |
|
2025
Q1 | $712K | Buy |
35,912
+5,027
| +16% | +$99.7K | ﹤0.01% | 1204 |
|
2024
Q4 | $530K | Buy |
30,885
+2,928
| +10% | +$50.2K | ﹤0.01% | 1340 |
|
2024
Q3 | $558K | Sell |
27,957
-3,374
| -11% | -$67.4K | ﹤0.01% | 1295 |
|
2024
Q2 | $350K | Hold |
31,331
| – | – | ﹤0.01% | 1441 |
|
2024
Q1 | $207K | Buy |
31,331
+3,715
| +13% | +$24.5K | ﹤0.01% | 1757 |
|
2023
Q4 | $125K | Buy |
27,616
+12,920
| +88% | +$58.4K | ﹤0.01% | 1842 |
|
2023
Q3 | $52.6K | Buy |
+14,696
| New | +$52.6K | ﹤0.01% | 1905 |
|